+
Site Tour
TACHYCARDIA

Tachycardia is a broad term for a variety of rapid cardiac arrhythmias.1,2 It is commonly associated with underlying cardiac abnormalities.1,2 If left untreated, in serious cases, this can lead to heart failure or cardiac arrest.3,4

SUMMARY OF GUIDELINES

2022 European Society of Cardiology (ESC) Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death.5

Non-sustained ventricular tachycardia (NSVT)

Patients with incidental NSVT (≥3 consecutive ventricular beats lasting <30 seconds) should undergo risk stratification and diagnostic assessment to determine whether the arrhythmia is idiopathic or related to underlying cardiac pathology.5

LEARN MORE:

2022 ESC GUIDELINES

Sustained monomorphic ventricular tachycardia (SMVT)

The majority of patients presenting with SMVT (continuous VT for at least 30 seconds or requiring intervention for termination) have underlying structural heart disease. Diagnostic assessment is important to determine the underlying etiology and identify patients with idiopathic VT.5

LEARN MORE:

2022 ESC GUIDELINES

Regular wide QRS complex tachycardia

Acute management of regular wide QRS complex tachycardia requires assessment of hemodynamic status and underlying etiology to guide appropriate treatment, including cardioversion when indicated.5

LEARN MORE:

2022 ESC GUIDELINES

Premature ventricular complexes, ventricular tachycardias and non-apparent structural heart disease

After excluding structural heart disease, management of idiopathic PVCs/VT is guided by symptoms, PVC burden, and PVC/VT origin, with catheter ablation recommended as first-line therapy for right ventricular outflow tract (RVOT) and fascicular PVCs/VT.5

LEARN MORE:

2022 ESC GUIDELINES

Connext
Hub

Learn emerging and established information on cardiovascular conditions and stroke prevention technologies.

Find out more

TV

References & Abbreviations

ALS, advanced life support; ARVC, arrhythmogenic right ventricular cardiomyopathy; CAD, coronary artery disease; CAG, coronary angiography; CCB, calcium channel blocker; CMR, cardiac magnetic resonance; ECG, electrocardiogram; EP, electrophysiological; LV, left ventricular; LVEF, left ventricular ejection fraction; N, No; NSVT, non-sustained ventricular tachycardia; (NT-)proBNP, N-terminal pro-B-type natriuretic peptide; PET-CT, positron emission tomography and computed tomography; PVC, premature ventricular complex; RV, right ventricular; RVOT, right ventricular outflow tract; SCD, sudden cardiac death; SHD, structural heart disease; SMVT, sustained monomorphic ventricular tachycardia; SVT, supraventricular tachycardia; T4, thyroxine; TSH, thyroid stimulating hormone; VA, ventricular arrhythmia; VT, ventricular tachycardia; Y, Yes.

  1. NHS. Heart rhythm problems (arrhythmia). Available at: www.nhs.uk/conditions/arrhythmia/. Accessed June 11, 2026.
  2. American Heart Association. Tachycardia: Fast heart rate. Available at: https://www.heart.org/en/health-topics/arrhythmia/about-arrhythmia/tachycardia--fast-heart-rate. Accessed June 11, 2026.
  3. Mayo Clinic. Supraventricular tachycardia – Symptoms and causes. Available at: www.mayoclinic.org/diseases-conditions/supraventricular-tachycardia/symptomscauses/syc-20355243. Accessed June 11, 2026.
  4. Mayo Clinic. Ventricular tachycardia – Symptoms and causes. Available at: www.mayoclinic.org/diseases-conditions/ventricular-tachycardia/symptoms-causes/syc-20355138. Accessed June 11, 2026.
  5. Zeppenfeld K, Tfelt-Hansen J, de Riva M, et al. 2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. Eur Heart J. 2022;43(40):3997–4126. doi: 10.1093/eurheartj/ehac262.

© Abbott 2026. All rights reserved. MAT-2676033 v1.0

You are about to leave my-connext.com

You are now leaving my-connext.com. Abbott is not responsible for any content published on the third-party website you are about to enter. Abbott has not reviewed and does not endorse any information presented on third-party websites.

The content on this website is intended for healthcare professionals in EMEA with applicable health authority product registrations, excepted those practicing in France as some of the content is not in compliance with the French Advertising law N°2011-2012 dated 29th December 2011 article 34. Click OK to confirm you are a healthcare professional to proceed.

OK Decline